Discovery of potent and selective inhibitors of 11β-HSD1 for the treatment of metabolic syndrome
摘要:
High throughput screening efforts have identified a novel class of dichloroaniline amide 11 beta-HSD1 inhibitors. SAR studies initiated from dichloroaniline 4 focused on retaining the potency and selectivity profile of the lead. (c) 2006 Elsevier Ltd. All rights reserved.